Glaxo nears $3 billion deal for U.S. dermatology drug maker: WSJ
April 19, 2009 at 18:51 PM EDT
GlaxoSmithKline is close to a deal to buy Stiefel Laboratories, a closely held U.S. maker of dermatology products, for about $3 billion, The Wall Street Journal reports.
